NEPH today
$3.07-$0.08 (-2.54%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bullish
1 hourStrong Bearish
15 minStrong Bearish
5 minConsolidating
Daily trend turns up above $4.87
Key levels
Resistance$3.79
Resistance$3.28
Support$3.01
Support$2.72
Latest news & SEC filings
EarningsNephros Reports Third Quarter 2026 Financial Results
EarningsNephros posts quarterly profit of $0.05 per share, topping $0.03 forecast
All NEPH news →About Nephros
Nephros makes and sells filtration systems installed at the tap or machine level for healthcare and commercial water treatment. Its medical offerings include FDA-cleared ultrafilters and microfilters used to control waterborne pathogens and to purify water and bicarbonate concentrate for dialysis. Its commercial filters target taste, odor, scaling, particles, lead, cysts, and PFAS. Buyers include hospitals, dialysis centers, restaurants, hotels, labs, and industrial sites, reached through resellers and an in-house sales team, mainly across the United States.
Based on the company's 10-K filed Mar 12, 2026.
Nasdaq · Healthcare
NEPHROS INC (NEPH)
What Is the Price Target for NEPH?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is NEPH a Buy or Sell Right Now?
Thesis
- •Revenue growing 32.7% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NEPH.
Start Free Trial →Is NEPH Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG
Fair Value
$3.75
65
Moat Score
NARROW
6/9
Piotroski Score
-6.1
Altman Z-Score
What Is Smart Money Doing with NEPH?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Amron Arthur H | director | Buy | 3,574 | - | May 11, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NEPH Growth Story
Revenue YoY
32.7%
3yr Revenue CAGR
23.5%
EPS Growth YoY
1000%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
Dark Pool Trades for NEPH
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NEPH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:23:41 | $3.28 | 5,000 | $$16K | SELL |
| 16:46:47 | $3.29 | 1,584 | $$5K | SELL |
| 16:05:00 | $3.02 | 2,000 | $$6K | MIDPOINT |
| 15:18:21 | $2.99 | 1,953 | $$6K | MIDPOINT |
| 15:15:33 | $2.99 | 2,000 | $$6K | BUY |
5 dark pool trades shown · $$39K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for NEPHROS INC (NEPH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NEPH — frequently asked questions
What is NEPH stock price today?
NEPHROS INC (NEPH) is at $3.07, down 2.54% (-$0.08) at the Nov 11, 2026 close.
Why is NEPH stock moving today?
Latest NEPH news — Nov 6, 2026: Nephros Reports Third Quarter 2026 Financial Results · Nov 5, 2026: Nephros posts quarterly profit of $0.05 per share, topping $0.03 forecast
What do analysts rate NEPH?
Analyst ratings for NEPH: 2 Buy, 1 Hold, 0 Sell — consensus Buy.
Did NEPH beat earnings?
NEPH last reported on Nov 5, 2026: EPS $0.05 vs $0.02 expected — a beat of 114.6%.
What is NEPH's P/E ratio?
NEPH trades at a P/E of 20.3 vs a Healthcare average of 18.5.
Does NEPH pay a dividend?
NEPH does not currently pay a dividend.
What are NEPH support and resistance levels?
Support: $3.01, $2.72, $2.28. Resistance: $3.28, $3.79, $4.05.
What are insiders doing with NEPH?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on NEPH?
Nov 6, 2026: Nephros Reports Third Quarter 2026 Financial Results · Nov 5, 2026: Nephros posts quarterly profit of $0.05 per share, topping $0.03 forecast